In 2000 was created Epicenter Technology, which is appeared as Corporate Investor. The company was established in Asia in India. The main department of described Corporate Investor is located in the Mumbai.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Canada. Among the most popular fund investment industries, there are Therapeutics, Health Care. Among the various public portfolio startups of the fund, we may underline Alethia BioTherapeutics
The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2010.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Epicenter Technology, startups are often financed by GO Capital Fund, BDC Venture Capital. The meaningful sponsors for the fund in investment in the same round are GO Capital Fund, BDC Venture Capital, AgeChem Venture Fund. In the next rounds fund is usually obtained by GO Capital Fund, BDC Venture Capital, AgeChem Venture Fund.
Related Funds
Fund Name | Location |
Aeternam Stella | China, Shanghai |
BPV Capital Management | Knoxville, Tennessee, United States |
Digicel | Jamaica, Kingston, Saint Andrew |
Elmspring Accelerator | Chicago, Illinois, United States |
Europeatweb | - |
Framestore | England, London, United Kingdom |
Huadie Touzi | China, Guangdong, Jiangxi |
I-Source Gestion | France, Ile-de-France, Paris |
KIDS HOLDINGS | Japan, Tokyo |
Kosciuszko Holdings | - |
LD Captial Culture Investment | Beijing, Beijing, China |
OTS Service ManagementResearch & Consulting | Japan, Naha, Okinawa Prefecture |
re.Mind Capital | Central Region, Malta, NA - Malta |
Rimonim Fund | Israel, South Dakota, United States |
Safa Partners | New York, New York, United States |
Shanghai Lanting Touzi | China, Shanghai, Xuhui |
Shanghai Shixi | China, Jinshan District |
Vidinovo | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Alethia BioTherapeutics | $9M | 07 Sep 2010 | Quebec |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Alethia BioTherapeutics | $9M | 07 Sep 2010 | Quebec |